Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 2
1979 3
1980 3
1981 3
1982 2
1983 3
1985 5
1986 3
1987 2
1988 3
1989 9
1990 6
1991 8
1992 8
1993 10
1994 8
1995 7
1996 8
1997 9
1998 15
1999 16
2000 21
2001 12
2002 15
2003 17
2004 19
2005 18
2006 25
2007 42
2008 45
2009 59
2010 57
2011 48
2012 58
2013 64
2014 89
2015 111
2016 101
2017 81
2018 107
2019 115
2020 113
2021 139
2022 121
2023 162
2024 65

Text availability

Article attribute

Article type

Publication date

Search Results

1,645 results

Results by year

Filters applied: . Clear all
Page 1
Sucrose signaling in higher plants.
Yoon J, Cho LH, Tun W, Jeon JS, An G. Yoon J, et al. Among authors: an g. Plant Sci. 2021 Jan;302:110703. doi: 10.1016/j.plantsci.2020.110703. Epub 2020 Oct 4. Plant Sci. 2021. PMID: 33288016 Review.
mRNA Vaccines: The Dawn of a New Era of Cancer Immunotherapy.
Deng Z, Tian Y, Song J, An G, Yang P. Deng Z, et al. Among authors: an g. Front Immunol. 2022 Jun 2;13:887125. doi: 10.3389/fimmu.2022.887125. eCollection 2022. Front Immunol. 2022. PMID: 35720301 Free PMC article. Review.
Camrelizumab Plus Carboplatin and Pemetrexed as First-Line Treatment for Advanced Nonsquamous NSCLC: Extended Follow-Up of CameL Phase 3 Trial.
Zhou C, Chen G, Huang Y, Zhou J, Lin L, Feng J, Wang Z, Shu Y, Shi J, Hu Y, Wang Q, Cheng Y, Wu F, Chen J, Lin X, Wang Y, Huang J, Cui J, Cao L, Liu Y, Zhang Y, Pan Y, Zhao J, Wang L, Chang J, Chen Q, Ren X, Zhang W, Fan Y, He Z, Fang J, Gu K, Dong X, Jin F, Gao H, An G, Ding C, Jiang X, Xiong J, Zhou X, Hu S, Lu P, Liu A, Guo S, Huang J, Zhu C, Zhao J, Gao B, Chen Y, Hu C, Zhang J, Zhang H, Zhao H, Tai Y, Ma X, Shi W; CameL Study Group. Zhou C, et al. Among authors: an g. J Thorac Oncol. 2023 May;18(5):628-639. doi: 10.1016/j.jtho.2022.12.017. Epub 2023 Jan 13. J Thorac Oncol. 2023. PMID: 36646210 Clinical Trial.
Sintilimab versus docetaxel as second-line treatment in advanced or metastatic squamous non-small-cell lung cancer: an open-label, randomized controlled phase 3 trial (ORIENT-3).
Shi Y, Wu L, Yu X, Xing P, Wang Y, Zhou J, Wang A, Shi J, Hu Y, Wang Z, An G, Fang Y, Sun S, Zhou C, Wang C, Ye F, Li X, Wang J, Wang M, Liu Y, Zhao Y, Yuan Y, Feng J, Chen Z, Shi J, Sun T, Wu G, Shu Y, Guo Q, Zhang Y, Song Y, Zhang S, Chen Y, Li W, Niu H, Hu W, Wang L, Huang J, Zhang Y, Cheng Y, Wu Z, Peng B, Sun J, Mancao C, Wang Y, Sun L. Shi Y, et al. Among authors: an g. Cancer Commun (Lond). 2022 Dec;42(12):1314-1330. doi: 10.1002/cac2.12385. Epub 2022 Nov 6. Cancer Commun (Lond). 2022. PMID: 36336841 Free PMC article. Clinical Trial.
1,645 results